"A Study of MSI-1256F (Squalamine Lactate) To Treat Wet Age-Related Macular Degeneration"

PHASE2TerminatedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

May 31, 2006

Conditions
Macular Degeneration
Interventions
DRUG

MSI-1256F (Squalamine Lactate)

Trial Locations (9)

11563

Ophthalmic Consultants of Long Island, Long Island City

14618

Retina Associates of Western New York, Rochester

21204

Retina Specialists, Towson

33136

Bascom Palmer Eye Institute, Miami

33426

Florida Eye Microsurgical Institute, Boynton Beach

33907

Retina Health Center, Fort Meyers

46280

Midwest Eye Institute, Indianapolis

64108

Eye Foundation of Kansas City, Kansas City

77002

Charles Garcia, MD, P.A., Houston

Sponsors
All Listed Sponsors
lead

Genaera Corporation

INDUSTRY